|
|
| Line 14: |
Line 14: |
| <span style="display:none">Spleen</span> | | <span style="display:none">Spleen</span> |
| <span style="display:none">Leukemia</span> | | <span style="display:none">Leukemia</span> |
| | <span style="display:none">isPatientResource</span> |
| <span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span> | | <span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span> |
| <span style="display:none">isPatientResource</span>
| |
| <span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | | <span style="display:none">hasCancerType::C00-D48: All neoplasms</span> |
| <span style="display:none">hasCancerType::C00-C97: All cancer types</span> | | <span style="display:none">hasCancerType::C00-C97: All cancer types</span> |
| <span style="display:none">hasCancerType::C00-C14: Mouth/throat cancers</span>
| |
| <span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span>
| |
| <span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span>
| |
| <span style="display:none">hasCancerType::C40-C41: Bone cancers</span>
| |
| <span style="display:none">hasCancerType::C43-C44: Skin cancers/melanoma</span>
| |
| <span style="display:none">hasCancerType::C45-C49: Soft tissue cancer</span>
| |
| <span style="display:none">hasCancerType::C50: Breast cancer</span>
| |
| <span style="display:none">hasCancerType::C51-C58: Female genitalia cancers</span>
| |
| <span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span>
| |
| <span style="display:none">hasCancerType::C64-C68: Urinary system cancers</span>
| |
| <span style="display:none">hasCancerType::C69-C72: Eye and brain cancer</span>
| |
| <span style="display:none">hasCancerType::C73-C75: Thyroid and other gland cancers</span>
| |
| <span style="display:none">hasCancerType::C76-C80: Cancers of unknown or unspecified areas</span>
| |
| <span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span>
| |
| <span style="display:none">hasCancerType::D00-D09: Early-stage cancers not yet spread</span>
| |
| <span style="display:none">hasCancerType::D10-D36: Benign tumour</span>
| |
| <span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span>
| |
| <span style="display:none">hasCancerType::unknown</span>
| |
forpatients
italycountry
Go back to European Institute of Oncology page
Primary purpose: To provide continuous medical support and 24-hour on-call assistance for patients with hematological malignancies, helping them manage unexpected signs or symptoms and emergencies that may arise due to their disease or treatment.
Cancer areas of interest: C81-C96: Cancers of the blood and immune system. Click here to learn more.
Information: Click here to access.
Blood
Bone marrow
Lymph nodes
Spleen
Leukemia
isPatientResource
hasCancerType::C81-C96: Cancers of the blood and immune system
hasCancerType::C00-D48: All neoplasms
hasCancerType::C00-C97: All cancer types
